Hana Pharm Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 1.34%

Hana Pharm Co Ltd (293480) has an Asset Resilience Ratio of 1.34% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Hana Pharm Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩5.43 Billion

≈ $3.68 Million USD Cash + Short-term Investments

Total Assets

₩405.15 Billion

≈ $274.57 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Hana Pharm Co Ltd's Asset Resilience Ratio has changed over time. See Hana Pharm Co Ltd net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Hana Pharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Hana Pharm Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩5.43 Billion	1.34%
Total Liquid Assets	₩5.43 Billion	1.34%

Asset Resilience Insights

Limited Liquidity: Hana Pharm Co Ltd maintains only 1.34% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Hana Pharm Co Ltd Industry Peers by Asset Resilience Ratio

Compare Hana Pharm Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
SIMCERE PHARMAC. GRP LTD F:S2P	Drug Manufacturers - Specialty & Generic	0.44%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%

Annual Asset Resilience Ratio for Hana Pharm Co Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Hana Pharm Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.95%	₩3.64 Billion ≈ $2.47 Million	₩382.01 Billion ≈ $258.88 Million	-0.41pp
2023-12-31	1.36%	₩4.73 Billion ≈ $3.21 Million	₩348.39 Billion ≈ $236.10 Million	-0.10pp
2022-12-31	1.46%	₩5.03 Billion ≈ $3.41 Million	₩345.96 Billion ≈ $234.46 Million	-15.10pp
2021-12-31	16.56%	₩50.25 Billion ≈ $34.05 Million	₩303.50 Billion ≈ $205.68 Million	-2.54pp
2020-12-31	19.10%	₩52.83 Billion ≈ $35.80 Million	₩276.58 Billion ≈ $187.43 Million	-9.19pp
2019-12-31	28.29%	₩74.42 Billion ≈ $50.44 Million	₩263.03 Billion ≈ $178.25 Million	-8.56pp
2018-12-31	36.85%	₩89.32 Billion ≈ $60.53 Million	₩242.38 Billion ≈ $164.26 Million	+34.34pp
2017-12-31	2.51%	₩3.55 Billion ≈ $2.41 Million	₩141.55 Billion ≈ $95.93 Million	+0.96pp
2016-12-31	1.54%	₩1.77 Billion ≈ $1.20 Million	₩114.59 Billion ≈ $77.66 Million	--

pp = percentage points

About Hana Pharm Co Ltd

KO:293480 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$107.86 Million

₩159.16 Billion KRW

Market Cap Rank

#18992 Global

#906 in Korea

Share Price

₩9200.00

Change (1 day)

-0.65%

52-Week Range

₩8830.00 - ₩12430.00

All Time High

₩26028.86